TerrAscend Corp. (TSND.TO)

CAD 0.94

(0.0%)

Market Cap (In CAD)

274.74 Million

Revenue (In CAD)

317.32 Million

Net Income (In CAD)

-91.1 Million

Avg. Volume

168.25 Thousand

Currency
CAD
Country
Healthcare
Open
-
Prev. Close
-
Day Range
-
Year Range
0.73-3.21
PE
-
EPS
-
Beta Value
1.89
ISIN
CA88105E1088
CUSIP
-
CIK
-
Shares
-
Earnings Annoncement
-

Company Profile

Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
CEO
Mr. Ziad Ghanem
Employee Count
-
Website
https://www.terrascend.com
Ipo Date
2017-05-03
Details
TerrAscend Corp. cultivates, processes, and sells medical and adult use cannabis in Canada and the United States. The company produces and distributes hemp-derived wellness products to retail locations; and manufactures cannabis-infused artisan edibles. It also operates retail dispensaries under the Apothecarium brand name in California, Pennsylvania, and New Jersey. In addition, the company owns various synergistic businesses under Gage Growth, Pinnacle, TerrAscend NJ, Ilera Healthcare, HMS Health and HMS Processing, Valhalla Confections, State Flower, Arise Bioscience Inc., and TerrAscend Canada brands. It serves medical and legal adult-use markets. The company was incorporated in 2017 and is headquartered in Mississauga, Canada.